TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. financial statements, including revenue, expenses, profit, and loss

The total revenue of 600211 for the last quarter is 697.31 M CNY, and it's 7.81% lower compared to the previous quarter. The net income of Q1 24 is 312.92 M CNY.